Case Study: Operationalizing RTU Vancomycin for Injection

Friday, May 5 | 1:00-1:20PM ET

Event Information

Given drug shortages and staffing challenges, adopting ready-to-use products can reduce compounding risks and simplify distribution. VANCO READY® Vancomycin Injection, USP, is a premix, room temperature stable formulation. VANCO READY® has a boxed warning and is not for use during first and second trimester of pregnancy. Cody Parsons will discuss the operationalization of RTU vancomycin, outlining important patient considerations, storage requirements, EHR adaptation, and workflow simplifications. For full prescribing and safety information please visit www.vancoready.com.

Speaker

Cody Parsons, APh, PharmD, BCCCP

Cody Parsons, APh, PharmD, BCCCP, is the Manager of Clinical Operations for the Cardiovascular Health (CVH) Service Line at a quaternary academic medical center located in the Bay Area in California. He manages the STEMI program, The Joint Commission and American Heart Association Comprehensive Cardiac Center Certification, and the Inpatient Cardiac Rehab Program and team. Cody also manages the CVH Quality Team, including the CVH related data registries. His clinical area of focus in pharmacy is critical care and other interests include hospital administration, regulation, and LGBTQ+ care.